Numerically, the largest multicentric study in the Brazilian population evaluated the prevalence of KRAS mutations in 8234 CRC samples and reported a prevalence of 31.9%, of which KRAS G12V was the most frequent, with most samples coming from the southeast region [25]. This evidence concerns the gene KRAS and colorectal carcinoma.